Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Aska Pharm. to Promote Lipidil, Expand Generic Business: President Yamaguchi
December 19, 2005
- REGULATORY NEWS IN BRIEF
December 19, 2005
- Aiming at Global Top 10: Astellas
December 19, 2005
- President & CEO Stephen J. Ubl Meets Japanese Stakeholders: AdvaMed
December 19, 2005
- Pegintron, Rebetol Show Strong Growth in Japan: Schering-Plough
December 19, 2005
- Tyco Healthcare Supports Spread of Laparoscopic Surgery
December 19, 2005
- Pfizer Japan Discusses Restructuring with Labor Union
December 19, 2005
- Osaka Univ. to Develop Training Method for Laparoscopic Surgery
December 19, 2005
- Banyu to Reorganize, Cut 300 Jobs
December 19, 2005
- MEDICAL DEVICE NEWS IN BRIEF
December 19, 2005
- BUSINESS NEWS IN BRIEF
December 19, 2005
- Tissue Engineering and Regenerative Medicine Workshop Held in Kobe
December 19, 2005
- Korosho Proposes Direction for FY2006 NHI Pricing System Reform
December 19, 2005
- Requirements for DPC Hospitals Proposed by Korosho
December 19, 2005
- (Proposed) Direction for FY2006 NHI Pricing System Reform
December 19, 2005
- Pollinosis Much More Common in Boys Under 10 Years of Age
December 19, 2005
- Korosho's Reform Proposal Would Weaken Industry: Mr Crenshaw of PhRMA
December 19, 2005
- Airborne Cedar Pollen Levels Should Be Lower in 2006
December 19, 2005
- Long-listed Drugs' NHI Price Reductions to Negatively Affect State Finances: OPIR
December 19, 2005
- JSCPT Annual Assembly Held in Beppu
December 19, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…